Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion, BUSULFAN, FILGRASTIM, PLERIXAFOR
CTX001-111
Phase 3 small_molecule active
Quick answer
Casgevy 4 - 13 x 10^6 cells/mL dispersion for infusion, BUSULFAN, FILGRASTIM, PLERIXAFOR for Transfusion-dependent β-thalassemia (TDT) is a Phase 3 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Transfusion-dependent β-thalassemia (TDT)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active